Based on molecular subtypes, AnxA2 expression was significantly elevated in tumor tissues and serum samples of triple-negative breast cancer (TNBC) patients compared with other breast cancer subtypes. The gene discussed is ANXA2; the disease is triple-negative breast carcinoma.